14.81
-1.88
(-11.26%)
At close: January 10 at 4:00:01 PM EST
14.81
0.00
(0.00%)
After hours: January 10 at 4:00:10 PM EST
Breakdown
12/31/2023
12/31/2022
Total Assets
155,423.00
31,603.00
Total Liabilities Net Minority Interest
181,057.00
41,665.00
Total Equity Gross Minority Interest
-25,634.00
-10,062.00
Total Capitalization
-25,634.00
-10,062.00
Common Stock Equity
-25,634.00
-10,062.00
Capital Lease Obligations
2,146.00
--
Net Tangible Assets
-25,634.00
-10,062.00
Working Capital
142,069.00
29,605.00
Invested Capital
-25,634.00
-10,062.00
Tangible Book Value
-25,634.00
-10,062.00
Total Debt
2,146.00
--
Share Issued
35,376.46
35,376.46
Ordinary Shares Number
35,376.46
35,376.46
12/31/2022 - 6/7/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTV Artiva Biotherapeutics, Inc.
9.35
-8.87%
MBX MBX Biosciences, Inc.
13.69
-5.65%
CTNM Contineum Therapeutics, Inc.
13.29
-0.60%
LXEO Lexeo Therapeutics, Inc.
6.39
-6.30%
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
BCAX Bicara Therapeutics Inc.
14.38
-5.70%
MLYS Mineralys Therapeutics, Inc.
9.87
-11.87%
CNTA Centessa Pharmaceuticals plc
15.64
-2.86%
IGMS IGM Biosciences, Inc.
2.0900
-66.29%
SEPN Septerna, Inc.
17.99
-13.72%